Celgene fends off Kyle Bass challenge
relif / Shutterstock.com
The Coalition for Affordable Drugs and Anacor Pharmaceuticals will face off in a dispute over the validity of two anti-fungal patents after the Patent Trial and Appeal Board (PTAB) gave the go-ahead to two inter partes review petitions.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
PTAB; USPTO; IPR; Anacor Pharmaceuticals; Kyle Bass;